DE69635517D1 - Menschliche neuronale acetylcholin-rezeptor verbindungen und methoden zu deren anwendung - Google Patents

Menschliche neuronale acetylcholin-rezeptor verbindungen und methoden zu deren anwendung

Info

Publication number
DE69635517D1
DE69635517D1 DE69635517T DE69635517T DE69635517D1 DE 69635517 D1 DE69635517 D1 DE 69635517D1 DE 69635517 T DE69635517 T DE 69635517T DE 69635517 T DE69635517 T DE 69635517T DE 69635517 D1 DE69635517 D1 DE 69635517D1
Authority
DE
Germany
Prior art keywords
alpha
subunits
beta
human neuronal
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69635517T
Other languages
English (en)
Other versions
DE69635517T2 (de
Inventor
J Elliott
M Harpold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69635517D1 publication Critical patent/DE69635517D1/de
Publication of DE69635517T2 publication Critical patent/DE69635517T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
DE69635517T 1995-06-07 1996-06-07 Menschliche neuronale acetylcholin-rezeptor verbindungen und methoden zu deren anwendung Expired - Fee Related DE69635517T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US484722 1995-06-07
US08/484,722 US6485967B1 (en) 1995-06-07 1995-06-07 Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
PCT/US1996/009775 WO1996041876A1 (en) 1995-06-07 1996-06-07 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same

Publications (2)

Publication Number Publication Date
DE69635517D1 true DE69635517D1 (de) 2006-01-05
DE69635517T2 DE69635517T2 (de) 2006-08-10

Family

ID=23925332

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635517T Expired - Fee Related DE69635517T2 (de) 1995-06-07 1996-06-07 Menschliche neuronale acetylcholin-rezeptor verbindungen und methoden zu deren anwendung

Country Status (9)

Country Link
US (5) US6485967B1 (de)
EP (2) EP1295945A1 (de)
JP (2) JPH11509726A (de)
AT (1) ATE311448T1 (de)
AU (1) AU704927B2 (de)
CA (1) CA2221311A1 (de)
DE (1) DE69635517T2 (de)
ES (1) ES2250993T3 (de)
WO (1) WO1996041876A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632823B1 (en) 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
DE19819829A1 (de) 1998-05-04 1999-11-11 Bayer Ag Nukleinsäuren, die für Acetylcholinrezeptor-Untereinheiten von Insekten kodieren
GB9913248D0 (en) * 1999-06-09 1999-08-04 Babraham Inst Recombinant nematode nicotinic receptor and uses
EP1090991A1 (de) * 1999-09-29 2001-04-11 Sanofi-Synthelabo Nikotin-acetylcholin-Rezeptor, dessen Isolierung und Verwendung
DE19959582A1 (de) * 1999-12-10 2001-06-13 Bayer Ag Nukleinsäuren, die für neue Acetylcholinrezeptor-beta-Untereinheiten von Insekten kodieren
WO2001044283A2 (en) * 1999-12-14 2001-06-21 Pharmacia & Upjohn Company Human ion channels
AU2001249650A1 (en) * 2000-04-03 2001-10-15 Anne Chew Haplotypes of the chrnb3 gene
FR2813499B1 (fr) * 2000-09-04 2004-11-26 Pasteur Institut Mammifere non-humain mutant pour l'expression de la sous- unite alpha6 du recepteur nicotinique de l'acetylcholine et utilisation pour le criblage de substances susceptibles d'interagir avec ce recepteur
AU2002324842C9 (en) 2001-08-31 2008-07-10 Agensys, Inc. 205P1B5 in treatment and detection of cancer
WO2005030145A2 (en) * 2003-09-24 2005-04-07 Targacept, Inc. Composition and pharmacology of novel alpha-6-containing nicotinic acetylcholine receptors
US7799683B2 (en) * 2004-11-08 2010-09-21 Tel Epion, Inc. Copper interconnect wiring and method and apparatus for forming thereof
US20070184656A1 (en) * 2004-11-08 2007-08-09 Tel Epion Inc. GCIB Cluster Tool Apparatus and Method of Operation
CN101180543B (zh) * 2005-02-23 2014-06-18 美国陶氏益农公司 使用烟碱乙酰胆碱受体亚单位的新检测方法
US7879913B2 (en) * 2005-06-28 2011-02-01 Catholic Healthcare West Iptakalim hydrochloride for decreasing nicotine use
US9005981B2 (en) * 2008-12-30 2015-04-14 Dow Agrosciences Llc Assays utilizing nicotinic acetylcholine receptor subunits

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
US4837148A (en) 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
US4855231A (en) 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5071773A (en) 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5024939A (en) 1987-07-09 1991-06-18 Genentech, Inc. Transient expression system for producing recombinant protein
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
US4981784A (en) 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US5449606A (en) 1988-03-18 1995-09-12 The Salk Institute For Biological Studies DNA encoding neuronal nicotinic acetylcholine receptor compositions containing the beta 4 subunit
CA1341554C (en) 1988-03-18 2007-10-09 The Salk Institute For Biological Studies Neuronal nicotinic acetylcholine receptor compositions and assay
CA1341170C (en) 1988-04-04 2001-01-16 Steven B. Ellis Calcium channel compositions and methods
US5386025A (en) 1990-02-20 1995-01-31 The Salk Institute Biotechnology/Industrial Associates Calcium channel compositions and methods
CA2047683C (en) 1989-03-14 2000-06-06 Stephen F. Heinemann Neuronal nicotinic acetylcholine receptor compositions containing the beta 4 subunit
AU648523B2 (en) 1989-10-25 1994-04-28 Salk Institute For Biological Studies, The Receptor infection assay
US5091518A (en) 1989-11-16 1992-02-25 The Salk Institute For Biological Studies Beta retinoic acid response elements compositions and assays
US5369028A (en) 1990-04-03 1994-11-29 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
EP0688361B1 (de) * 1993-03-08 2004-10-13 Merck & Co., Inc. Menschliche neuronale nikotin-acetylcholin-rezeptor-verbindungen und methoden ihres einsatzes
WO1995013299A1 (en) 1993-11-08 1995-05-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Human neuronal nicotinic acetylcholine receptor compositions and methods employing same

Also Published As

Publication number Publication date
US7169895B2 (en) 2007-01-30
US6524789B1 (en) 2003-02-25
US20040002122A1 (en) 2004-01-01
EP0832230B1 (de) 2005-11-30
AU704927B2 (en) 1999-05-06
EP0832230A1 (de) 1998-04-01
JP2009050270A (ja) 2009-03-12
WO1996041876A1 (en) 1996-12-27
DE69635517T2 (de) 2006-08-10
EP1295945A1 (de) 2003-03-26
ATE311448T1 (de) 2005-12-15
US6485967B1 (en) 2002-11-26
CA2221311A1 (en) 1996-12-27
ES2250993T3 (es) 2006-04-16
US7119067B2 (en) 2006-10-10
US20070185313A1 (en) 2007-08-09
AU6266496A (en) 1997-01-09
JPH11509726A (ja) 1999-08-31
US20030138911A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
DE69635517D1 (de) Menschliche neuronale acetylcholin-rezeptor verbindungen und methoden zu deren anwendung
ATE279516T1 (de) Menschliche neuronale nikotin-acetylcholin- rezeptor-verbindungen und methoden ihres einsatzes
DE3860769D1 (de) Polymer-zusammensetzung, verfahren zu deren herstellung und deren anwendung.
DE3787275T2 (de) Schlagzähe Polyamidharz-Zusammensetzung und Verfahren zu deren Herstellung.
DE68907956D1 (de) Verbindungen, die ueber 120 grad k supraleitend sind und verfahren zu deren herstellung.
DE3679660D1 (de) Alkoxylierte und kationisch modifizierte amidgruppen enthaltende polymere und verfahren zu deren herstellung.
DE3775486D1 (de) Thermoplast-kautschuk-polymerlegierung und verfahren zu deren herstellung.
DE68923204T2 (de) Faserverstärkte Polyamid-Zusammensetzung und Verfahren zu deren Herstellung.
DE68901771T2 (de) Phospholipid enthaltende zusammensetzung, verfahren zu deren herstellung und verwendung als hilfsstoff fuer pharmazeutische substanzen.
DE68923959T2 (de) Glykosid-derivate, polymere enthaltend glykosid-derivate, verfahren zur herstellung und deren verwendung.
DE3789504T2 (de) Optisch aktive azetidinone und verfahren zu deren herstellung.
DE68920061D1 (de) Hydrofile, feine Gelpartikel und Verfahren zu deren Herstellung.
DE3762846D1 (de) Optisch aktive tolanderivate und verfahren zu deren herstellung.
ES2179352T3 (es) Compuesto de pirazolopiridina y su uso farmaceutico.
DE3782534T2 (de) Pechbasierte kohlenstoffasern mit hohem elastizitaetsmodul und verfahren zu deren herstellung.
DE3872620D1 (de) (arylsulphonyl)-nitromethane, verfahren zu deren herstellung und deren verwendung in pharmazeutischen zusammensetzungen.
PT88348A (pt) Processo para a marcacao de substancias com isotopos de tecnecio ou de renio
DE3785547D1 (de) Thermoplastische elastomerzusammensetzung und verfahren zu deren herstellung.
DE68917029T2 (de) Tetrazaporphin, Verfahren zu dessen Herstellung sowie optische Aufzeichnungsmaterialien und deren Herstellungsverfahren.
DE377274T1 (de) Adamantan-derivate, verfahren zu deren herstellung, diese enthaltende mittel sowie deren verwendung als organoleptika und deodorantien.
GB2287941A (en) Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
DE3669320D1 (de) Oxalkylierte polyesteramine,verfahren zu deren herstellung und deren verwendung.
DE58904853D1 (de) Isocyanat- und saeureanhydridgruppen enthaltende copolymerisate, ein verfahren zu ihrer herstellung und ihre verwendung als bindemittelkomponente.
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
DE3782599T2 (de) Laser mit monolitisch integrierten, planaren elementen und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK & CO., INC., RAHWAY, N.J., US

8339 Ceased/non-payment of the annual fee